Chad Tang, MD

Chad Tang is a radiation oncologist at MD Anderson Cancer Center and associate professor in the department of genitourinary radiation oncology. He holds joint appointments in the department of investigational cancer therapeutics and translational molecular pathology. He received his MD from Stanford University and completed residency at MD Anderson Cancer Center. His research and clinical practice focus on the treatment of advanced prostate and renal cell carcinomas with an emphasis on oligometastatic and oligoprogressive patients. He has completed and continues to run several investigator-initiated clinical trials investigating these disease states with a translational emphasis on immune and circulating tumor bioanalytes.

Financial relationships

Attribution:
Self

Type of financial relationship:
Grant Or Contract

Ineligible company:
Merck

Topic:
Pembrolizumab for trial support

Date added:
05/07/2026

Date updated:
05/07/2026
Attribution:
Self

Type of financial relationship:
Grant Or Contract

Ineligible company:
Myriad Genetics

Topic:
Financial and assay support

Date added:
05/07/2026

Date updated:
05/07/2026
Attribution:
Self

Type of financial relationship:
Consulting Fee

Ineligible company:
J&J

Topic:
Advisory Board

Date added:
05/07/2026

Date updated:
05/07/2026
Attribution:
Self

Type of financial relationship:
Consulting Fee

Ineligible company:
Elekta

Date added:
05/07/2026

Date updated:
05/07/2026
Attribution:
Self

Type of financial relationship:
Consulting Fee

Ineligible company:
Bayer

Topic:
Advisory Board

Date added:
05/07/2026

Date updated:
05/07/2026

Return to Oct. 9, 2026 - 5th Annual GU Cancer Symposium - Advances in Kidney Cancer